Latest updates for Acrxf
Fresh curated links around ACRXF are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
- Axsome Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation
- AIxCrypto Holdings, Inc. (AIXC) Q2 2026 Earnings Call Transcript
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Axsome Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation
AIxCrypto Holdings, Inc. (AIXC) Q2 2026 Earnings Call Transcript
AIxCrypto Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation
Recursion (RXRX) Q2 2026 Earnings Call Transcript
AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.
Shell: ARC Acquisition Shows The Flexibility When Responding To The Middle East Situation
argenx SE (ARGX) Forte Biosciences, Inc. - M&A Call - Slideshow
Recursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
AXA XL to Acquire Corporate Intelligence and Cyber Security Consultancy, S-RM
AXA XL announced it has entered into an agreement to acquire S-RM, the London-based specialist corporate intelligence and cyber security consultancy — raising its shareholding from...
What This $1.1 Million Insider Sale at Accelerant Means for Investors
Executed under a pre-arranged Rule 10b5-1 plan, the transaction reduces Radke's stake by just 0.28%, leaving him with ~28.6 million shares worth $379 million.
The a2 Milk Company Limited (ACOPY) Q4 2026 Earnings Call Transcript
Xryma Means "Money" in Greek. Its Euronext Paris Debut Won't Raise Any
Xryma, which was recently rebranded from ISX Financial EU, has received approval from the Cyprus Securities and Exchange Commission for the prospectus governing the admission of it...
ASX Limited 2026 Q4 - Results - Earnings Call Presentation
X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)
XCF Global (Nasdaq:SAFX) Surpasses Approximately $1 Million in Initial Commercial Revenue from New Rise Renewables Facil...
Milestone marks a crucial operational achievement and the Company's transition to active commercial revenue generation
AXT: Correction Has Provided An Opportunity For Speculative Investors - Buy (Rating Upgrade)
Rexford Industrial Realty, Inc. (REXR) Q2 2026 Earnings Call Transcript
RXO: Expectations Seem Imaginary As Core Metrics Worsen In Q2
Elixir Energy Limited (ELXPF) Shareholder/Analyst Call - Slideshow
Acquisitive Strategy Offers Long-Term Prospects for QXO Inc. (QXO) Despite Dilution and Integration Risks
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.